Breaking News Instant updates and real-time market news.

GILD

Gilead

$73.06

0.03 (0.04%)

07:16
10/14/16
10/14
07:16
10/14/16
07:16

Gilead's Harvoni designated as orphan treatment of chronic HCV in children

Gilead's Harvoni was designated for orphan status by the FDA as a treatment of chronic hepatitis C virus infection in pediatric patients, according to a post to the agency's website. Reference Link

  • 06

    Nov

  • 11

    Nov

  • 29

    Nov

GILD Gilead
$73.06

0.03 (0.04%)

09/27/16
LEER
09/27/16
DOWNGRADE
Target $94
LEER
Market Perform
Gilead downgraded to Market Perform from Outperform at Leerink
Leerink analyst Geoffrey Porges downgraded Gilead Sciences to Market Perform from Outperform and lowered his price target for the shares to $94 from $112. The biotech closed yesterday down 75c to $80.62. The analyst says he's now "outright bearish" on the company's Hepatitis C virus business. Gilead's HCV revenues will "decline faster, and farther," than the current consensus estimates forecast, Porges tells investors in a research note.
09/27/16
09/27/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Gilead (GILD) downgraded to Market Perform from Outperform at Leerink with analyst Geoffrey Porges saying he's now "outright bearish" on the company's Hepatitis C virus business. 2. J.M. Smucker (SJM) downgraded to Neutral from Outperform at Credit Suisse with analyst Robert Moskow saying that while the company raised its cost savings target as expected, he underestimated the hit to sales from difficult comparisons. 3. Discovery (DISCA) and Scripps Networks (SNI) downgraded to Sell from Neutral at MoffettNathanson. 4. Carter's (CRI) downgraded to Market Perform from Outperform at Wells Fargo with analyst Ike Boruchow saying his quarter-to-date store checks indicate "choppy" retail traffic trends and "deeper" pricing/promotional pressure. 5. Dollar Tree (DLTR) downgraded to Underweight from Neutral at Atlantic Equities with analyst Sam Hudson saying the second half comp inflection expected by consensus is "too demanding" and he expects multiple contraction if Family Dollar does not turn around. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
10/03/16
LEER
10/03/16
NO CHANGE
LEER
Market Perform
AASLD abstracts hint at potential competitive threat to Gilead HCV, says Leerink
Leerink analyst Geoffrey Porges says abstracts for the American Association for the Study of Liver Diseases, or AASLD, meeting revealed very limited efficacy information about the new Hepatitis C regimens for Gilead (GILD), Merck (MRK) and AbbVie (ABBV). Nonetheless, the analyst believes the abstracts hint at the potential competitive threat to Gilead's HCV dominance. While the new 12-week HCV regimens may compete on price, the forthcoming 8-week regimens put the most pressure on Gilead's market share, Porges argues. He reiterates a Market Perform rating on Gilead's shares.
10/03/16
RBCM
10/03/16
NO CHANGE
Target $95
RBCM
Outperform
Gilead HIV franchise could see risk from competitor data, says RBC Capital
RBC Capital analyst Michael Yee said his conversations with doctors leads him to think two dolutegravir HIV "doublet" studies being conducted by GlaxoSmithKline (GSK) and ViiV Healthcare - Glaxo's joint venture with Pfizer (PFE) and Shionogi - are likely to work and present an underappreciated risk to Gilead's (GILD) HIV franchise. Talks with investors lead Yee to believe few are even aware of this risk and that the consensus view is underestimating the probability these non-inferiority trials will work. Arguing that the consensus view should factor in more conservative assumptions for Gilead's HIV business post 2018 due to this risk, Yee cut his price target on Gilead to $95 from $105, but keeps an Outperform rating on the shares.

TODAY'S FREE FLY STORIES

AUDC

AudioCodes

$6.62

0.11 (1.69%)

05:51
04/26/17
04/26
05:51
04/26/17
05:51
Earnings
AudioCodes reports Q1 EPS 7c, consensus 7c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CREE

Cree

$24.82

0.07 (0.28%)

05:51
04/26/17
04/26
05:51
04/26/17
05:51
Downgrade
Cree rating change  »

Cree downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    May

BIG

Big Lots

$49.57

-0.36 (-0.72%)

05:49
04/26/17
04/26
05:49
04/26/17
05:49
Upgrade
Big Lots rating change  »

Big Lots upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

APTI

Apptio

$12.80

0.09 (0.71%)

05:48
04/26/17
04/26
05:48
04/26/17
05:48
Upgrade
Apptio rating change  »

Apptio upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    May

NORD

Nord Anglia

$32.82

5.2 (18.83%)

05:46
04/26/17
04/26
05:46
04/26/17
05:46
Downgrade
Nord Anglia rating change  »

Nord Anglia downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

AKS

AK Steel

$6.40

-0.72 (-10.11%)

05:44
04/26/17
04/26
05:44
04/26/17
05:44
Recommendations
AK Steel analyst commentary  »

AK Steel selloff a buying…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    May

CMG

Chipotle

$471.76

2.97 (0.63%)

05:43
04/26/17
04/26
05:43
04/26/17
05:43
Downgrade
Chipotle rating change  »

Chipotle downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SHOP

Shopify

$76.65

0.82 (1.08%)

05:43
04/26/17
04/26
05:43
04/26/17
05:43
Downgrade
Shopify rating change  »

Shopify downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

  • 24

    May

ALGT

Allegiant Travel

$163.85

-1.2 (-0.73%)

05:40
04/26/17
04/26
05:40
04/26/17
05:40
Downgrade
Allegiant Travel rating change  »

Allegiant Travel…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DYN

Dynegy

$6.19

-0.11 (-1.75%)

05:37
04/26/17
04/26
05:37
04/26/17
05:37
Upgrade
Dynegy rating change  »

Dynegy upgraded to Hold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    May

RSPP

RSP Permian

$38.69

1.32 (3.53%)

05:33
04/26/17
04/26
05:33
04/26/17
05:33
Initiation
RSP Permian initiated  »

RSP Permian reinstated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    May

CPE

Callon Petroleum

$12.24

0.39 (3.29%)

05:32
04/26/17
04/26
05:32
04/26/17
05:32
Initiation
Callon Petroleum initiated  »

Callon Petroleum…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    May

LOGI

Logitech

$31.79

0.99 (3.21%)

05:32
04/26/17
04/26
05:32
04/26/17
05:32
Earnings
Logitech backs FY18 outlook of high single-digit retail sales growth »

Logitech confirmed its…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

FSNN

Fusion Telecommunications

$1.43

0.01 (0.70%)

05:31
04/26/17
04/26
05:31
04/26/17
05:31
Initiation
Fusion Telecommunications initiated  »

Fusion Telecommunications…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

LOGI

Logitech

$31.79

0.99 (3.21%)

05:30
04/26/17
04/26
05:30
04/26/17
05:30
Earnings
Logitech reports Q4 EPS 15c, consensus 17c »

Reports Q4 revenue $496M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

SKYAY

Sky

$50.26

0.05 (0.10%)

05:29
04/26/17
04/26
05:29
04/26/17
05:29
Upgrade
Sky rating change  »

Sky upgraded to Buy from…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WFC

Wells Fargo

$54.56

0.91 (1.70%)

05:26
04/26/17
04/26
05:26
04/26/17
05:26
Hot Stocks
Wells Fargo issues statement in response to CA State Treasurer John Chiang »

"Notwithstanding the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 11

    May

  • 31

    May

  • 13

    Jul

  • 12

    Oct

  • 15

    Jan

KLRE

KLR Energy Acquisition

$10.55

0.1384 (1.33%)

04:55
04/26/17
04/26
04:55
04/26/17
04:55
Conference/Events
KLR Energy Acquisition to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

IONS

Ionis Pharmaceuticals

$47.88

2.14 (4.68%)

04:55
04/26/17
04/26
04:55
04/26/17
04:55
Conference/Events
Ionis Pharmaceuticals management to meet with Needham »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 26

    Apr

  • 24

    May

ADMS

Adamas Pharmaceuticals

$16.36

0.51 (3.22%)

, AVXS

AveXis

$78.74

-0.44 (-0.56%)

04:55
04/26/17
04/26
04:55
04/26/17
04:55
Conference/Events
American Academy of Neurology »

69th Annual Meeting of…

ADMS

Adamas Pharmaceuticals

$16.36

0.51 (3.22%)

AVXS

AveXis

$78.74

-0.44 (-0.56%)

CATB

Catabasis Pharmaceuticals

$1.48

-0.02 (-1.33%)

MNOV

MediciNova

$5.57

0.14 (2.58%)

IONS

Ionis Pharmaceuticals

$47.88

2.14 (4.68%)

FLKS

Flex Pharma

$3.07

0.01 (0.33%)

TGTX

TG Therapeutics

$12.00

1.6 (15.38%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 26

    Apr

  • 24

    May

  • 05

    Jun

  • 05

    Jun

  • 06

    Jun

  • 24

    Aug

ATEC

Alphatec

$1.98

0.02 (1.02%)

, CAE

CAE

$15.39

0.01 (0.07%)

04:55
04/26/17
04/26
04:55
04/26/17
04:55
Conference/Events
American Association of Neurological Surgeons to hold annual meeting »

2017 AANS Annual…

ATEC

Alphatec

$1.98

0.02 (1.02%)

CAE

CAE

$15.39

0.01 (0.07%)

EDGE

Edge Therapeutics

$10.72

1.07 (11.09%)

MDT

Medtronic

$81.76

1.11 (1.38%)

NUVA

NuVasive

$76.94

0.59 (0.77%)

SYK

Stryker

$135.59

1.14 (0.85%)

VRTX

Vertex

$117.27

-0.39 (-0.33%)

SYNA

Synaptics

$52.54

0.84 (1.62%)

NVIV

InVivo Therapeutics

$4.00

0.05 (1.27%)

LMAT

LeMaitre

$25.63

0.17 (0.67%)

MZOR

Mazor Robotics

$34.74

0.98 (2.90%)

OFIX

Orthofix

$39.28

0.19 (0.49%)

SSNLF

Samsung

SIEGY

Siemens

$72.70

0.615 (0.85%)

SNE

Sony

$33.65

-0.17 (-0.50%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 27

    Apr

  • 27

    Apr

  • 02

    May

  • 03

    May

  • 03

    May

  • 18

    May

  • 24

    May

  • 25

    May

  • 31

    May

  • 06

    Jun

ABUS

Arbutus Biopharma

$3.35

0.05 (1.52%)

04:55
04/26/17
04/26
04:55
04/26/17
04:55
Conference/Events
Arbutus Biopharma management to meet with William Blair »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

SXL

Sunoco Logistics

$24.35

0.64 (2.70%)

, ETP

Energy Transfer Partners

$36.42

0.98 (2.77%)

04:55
04/26/17
04/26
04:55
04/26/17
04:55
Conference/Events
Energy Transfer Partners to host special shareholder meeting »

Special Shareholder…

SXL

Sunoco Logistics

$24.35

0.64 (2.70%)

ETP

Energy Transfer Partners

$36.42

0.98 (2.77%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 23

    May

TIG

TiGenix

$16.36

0.08 (0.49%)

04:55
04/26/17
04/26
04:55
04/26/17
04:55
Conference/Events
TiGenix management to meet with Canaccord »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 27

    Apr

MTSI

MACOM

$53.84

-0.17 (-0.31%)

, SBGI

Sinclair Broadcast

$39.30

-0.15 (-0.38%)

04:55
04/26/17
04/26
04:55
04/26/17
04:55
Conference/Events
National Association of Broadcasters to hold a conference »

NAB Show 2017 is being…

MTSI

MACOM

$53.84

-0.17 (-0.31%)

SBGI

Sinclair Broadcast

$39.30

-0.15 (-0.38%)

NXST

Nexstar

$68.90

0.3 (0.44%)

TRCO

Tribune Media

$36.55

-0.08 (-0.22%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    May

  • 09

    May

  • 22

    May

  • 23

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.